GGrantIndex
← Leaderboards

Charles Leslie Hoppel

Case Western Reserve University

$9,267,801
Attributed
$9,319,313
Total exposure
11
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200515
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15

Funding mix

By agency

NIH$17,377,737 · 12

By mechanism

P01$14,854,689 · 8
P30$1,110,501 · 1
R01$1,071,772 · 1
R21$237,750 · 1
R56$103,025 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Mitochondria

Research focus

MitochondriaSamplingAgingHeartMyocardial Ischemia /HypoxiaCardiolipinsResearch StudyElectron TransportModificationProteinsAffectFatty AcidsMalonyl Coenzyme ACardiacDesignPhospholipidsLipidsMolecular WeightReperfusionBaseMetabolicOxidative StressQuality ControlAnalytical Method

Grant awards (56)

Aged rat heart mitochondrial dysfunction: proteome and lipidome dynamics$237,750
R21 · FY2015 · AG · contact PI
Fatty acid/branched-chain amino acid metabolism in hematopoietic stem cells$103,025
R56 · FY2014 · DK
Mitochondrial Dysfunction in heart Failure$252,251
P01 · FY2013 · HL · contact PI
Mitochondria/Mass Spectroscopy Core$173,760
P01 · FY2013 · HL · contact PI
Mitochondrial Dysfunction in heart Failure$278,845
P01 · FY2012 · HL · contact PI
Mitochondria/Mass Spectroscopy Core$278,845
P01 · FY2012 · HL · contact PI
Mitochondria/Mass Spectroscopy Core$278,846
P01 · FY2011 · HL · contact PI
Mitochondrial Dysfunction in heart Failure$278,845
P01 · FY2011 · HL · contact PI
CANCER PHARMACOLOGY CORE$142,873
P30 · FY2011 · CA · contact PI
Mitochondria/Mass Spectroscopy Core$278,846
P01 · FY2010 · HL · contact PI
Mitochondrial Dysfunction in heart Failure$278,845
P01 · FY2010 · HL · contact PI
CANCER PHARMACOLOGY CORE$155,934
P30 · FY2010 · CA · contact PI
Mitochondria/Mass Spectroscopy Core$286,658
P01 · FY2009 · HL · contact PI
Mitochondrial Dysfunction in heart Failure$286,658
P01 · FY2009 · HL · contact PI
CANCER PHARMACOLOGY CORE$148,082
P30 · FY2009 · CA · contact PI
Aging Heart: Basis of Increased Ischemic/Reflow Injury$1,303,445
P01 · FY2008 · AG · contact PI
Regulation of Liver CPT-I during Diabetic Ketosis$258,417
R01 · FY2008 · DK · contact PI
ANALYTICAL/CHEMISTRY CORE$222,815
P01 · FY2008 · AG · contact PI
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$200,149
P01 · FY2008 · AG · contact PI
MITOCHONDRIAL/STRUCTURAL CORE$187,150
P01 · FY2008 · AG · contact PI
CANCER PHARMACOLOGY CORE$159,403
P30 · FY2008 · CA · contact PI
Aging Heart: Basis of Increased Ischemic/Reflow Injury$1,293,249
P01 · FY2007 · AG · contact PI
Core D-- Mitochoindria Core$365,431
P01 · FY2007 · HL · contact PI
Regulation of Liver CPT-I during Diabetic Ketosis$263,690
R01 · FY2007 · DK · contact PI
ANALYTICAL/CHEMISTRY CORE$220,323
P01 · FY2007 · AG · contact PI
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$198,742
P01 · FY2007 · AG · contact PI
MITOCHONDRIAL/STRUCTURAL CORE$185,793
P01 · FY2007 · AG · contact PI
CANCER PHARMACOLOGY CORE$87,491
P30 · FY2007 · CA · contact PI
Aging Heart: Basis of Increased Ischemic/Reflow Injury$1,287,777
P01 · FY2006 · AG · contact PI
Core D-- Mitochoindria Core$306,814
P01 · FY2006 · HL · contact PI
Regulation of Liver CPT-I during Diabetic Ketosis$271,565
R01 · FY2006 · DK · contact PI
ANALYTICAL/CHEMISTRY CORE$159,392
P01 · FY2006 · AG · contact PI
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$143,760
P01 · FY2006 · AG · contact PI
MITOCHONDRIAL/STRUCTURAL CORE$134,409
P01 · FY2006 · AG · contact PI
Aging Heart: Basis of Increased Ischemic/Reflow Injury$1,283,492
P01 · FY2005 · AG
Core D-- Mitochoindria Core$298,355
P01 · FY2005 · HL
Regulation of Liver CPT-I during Diabetic Ketosis$278,100
R01 · FY2005 · DK
ANALYTICAL/CHEMISTRY CORE$154,235
P01 · FY2005 · AG
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$140,419
P01 · FY2005 · AG
MITOCHONDRIAL/STRUCTURAL CORE$130,210
P01 · FY2005 · AG
Aging Heart: Basis of Increased Ischemic/Reflow Injury$1,198,132
P01 · FY2004 · AG
Core D-- Mitochoindria Core$290,123
P01 · FY2004 · HL
ANALYTICAL/CHEMISTRY CORE$149,800
P01 · FY2004 · AG
MITOCHONDRIAL/STRUCTURAL CORE$131,369
P01 · FY2004 · AG
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$127,584
P01 · FY2004 · AG
ADMINISTRATIVE CORE$61,981
P01 · FY2004 · AG
CORE--CANCER PHARMACOLOGY FACILITY$78,870
P30 · FY2002 · CA
AGING HEART--BASIS OF INCREASED ISCHEMIC/REFLOW INJURY$802,394
P01 · FY2001 · AG
CORE--CANCER PHARMACOLOGY FACILITY$78,870
P30 · FY2001 · CA
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$0
P01 · FY2001 · AG
CORE--ANALYTICAL$0
P01 · FY2001 · AG
AGING HEART--BASIS OF INCREASED ISCHEMIC/REFLOW INJURY$889,935
P01 · FY2000 · AG
CORE--CLINICAL PHARMACOLOGY FACILITY$180,108
P30 · FY2000 · CA
CORE--ANALYTICAL$157,506
P01 · FY2000 · AG
FATTY ACID OXIDATION IN ISCHEMIC/REPERFUSED AGING HEARTS$157,506
P01 · FY2000 · AG
CORE--CLINICAL PHARMACOLOGY FACILITY$78,870
P30 · FY2000 · CA